WITHTECH Co., LTD. (KOSDAQ:348350)
9,220.00
+470.00 (5.37%)
At close: Oct 16, 2026
WITHTECH Co., LTD. Revenue
WITHTECH Co., LTD. had revenue of 18.30B KRW in the quarter ending June 30, 2026, with 70.86% growth. This brings the company's revenue in the last twelve months to 64.18B, up 38.55% year-over-year. In the year 2025, WITHTECH Co., LTD. had annual revenue of 57.81B with 32.54% growth. That makes WITHTECH Co., LTD. the 28,271st largest company in the world by revenue and 1,719th in South Korea.
Revenue (ttm)
64.18B
Revenue Growth
+38.55%
P/S Ratio
1.37
Revenue / Employee
280.27M
Employees
229
Market Cap
88.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.81B | 14.19B | 32.54% |
| Dec 31, 2024 | 43.62B | -5.95B | -12.00% |
| Dec 31, 2023 | 49.56B | -23.04B | -31.74% |
| Dec 31, 2022 | 72.61B | 4.30B | 6.29% |
| Dec 31, 2021 | 68.31B | 12.69B | 22.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kx Hitech | 142.48B |
| Cellumed | 119.81B |
| Amosense | 116.93B |
| CMG Pharmaceutical | 115.71B |
| WINPAC | 94.98B |
| NRB Inc. | 73.71B |
| HLB bioStep | 72.15B |
| GFI Co., Ltd. | 66.73B |